These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37211889)

  • 1. Levetiracetam and Midazolam vs Midazolam Alone for First-Line Treatment of Children With Generalized Convulsive Status Epilepticus (Lev-Mid Study): A Randomized Controlled Trial.
    Elshater AA; Sadek AA; Abdelkreem E
    Indian Pediatr; 2023 Aug; 60(8):630-636. PubMed ID: 37211889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.
    Appleton RE; Rainford NE; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee E; Potter S; Tate P; Al Najjar N; Iyer A; Evans V; Lyttle MD
    Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Levetiracetam vs. Phenytoin as Second Line Antiseizure Medication for Pediatric Convulsive Status Epilepticus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Angurana SK; Suthar R
    J Trop Pediatr; 2021 May; 67(2):. PubMed ID: 34089322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children.
    McTague A; Martland T; Appleton R
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD001905. PubMed ID: 29320603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the efficacy of sodium valproate and levetiracetam following initial lorazepam in elderly patients with generalized convulsive status epilepticus (GCSE): A prospective randomized controlled pilot study.
    Nene D; Mundlamuri RC; Satishchandra P; Prathyusha PV; Nagappa M; Bindu PS; Raghavendra K; Saini J; Bharath RD; Thennarasu K; Taly AB; Sinha S
    Seizure; 2019 Feb; 65():111-117. PubMed ID: 30682680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-hospital and emergency department treatment of convulsive status epilepticus in adults: an evidence synthesis.
    Cruickshank M; Imamura M; Booth C; Aucott L; Counsell C; Manson P; Scotland G; Brazzelli M
    Health Technol Assess; 2022 Mar; 26(20):1-76. PubMed ID: 35333156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam in toxic seizures.
    Lee T; Warrick BJ; Sarangarm P; Alunday RL; Bussmann S; Smolinske SC; Seifert SA
    Clin Toxicol (Phila); 2018 Mar; 56(3):175-181. PubMed ID: 28753046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre randomised controlled trial of levetiracetam versus phenytoin for convulsive status epilepticus in children (protocol): Convulsive Status Epilepticus Paediatric Trial (ConSEPT) - a PREDICT study.
    Dalziel SR; Furyk J; Bonisch M; Oakley E; Borland M; Neutze J; Donath S; Sharpe C; Harvey S; Davidson A; Craig S; Phillips N; George S; Rao A; Cheng N; Zhang M; Sinn K; Kochar A; Brabyn C; Babl FE;
    BMC Pediatr; 2017 Jun; 17(1):152. PubMed ID: 28641582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial.
    Navarro V; Dagron C; Elie C; Lamhaut L; Demeret S; Urien S; An K; Bolgert F; Tréluyer JM; Baulac M; Carli P;
    Lancet Neurol; 2016 Jan; 15(1):47-55. PubMed ID: 26627366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticonvulsant therapy for status epilepticus.
    Prasad M; Krishnan PR; Sequeira R; Al-Roomi K
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD003723. PubMed ID: 25207925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonintravenous midazolam versus intravenous or rectal diazepam for the treatment of early status epilepticus: A systematic review with meta-analysis.
    Brigo F; Nardone R; Tezzon F; Trinka E
    Epilepsy Behav; 2015 Aug; 49():325-36. PubMed ID: 25817929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial.
    Dalziel SR; Borland ML; Furyk J; Bonisch M; Neutze J; Donath S; Francis KL; Sharpe C; Harvey AS; Davidson A; Craig S; Phillips N; George S; Rao A; Cheng N; Zhang M; Kochar A; Brabyn C; Oakley E; Babl FE;
    Lancet; 2019 May; 393(10186):2135-2145. PubMed ID: 31005386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Phenytoin, Valproate and Levetiracetam in Pediatric Convulsive Status Epilepticus: A Randomized Double-blind Controlled Clinical Trial.
    Vignesh V; Rameshkumar R; Mahadevan S
    Indian Pediatr; 2020 Mar; 57(3):222-227. PubMed ID: 32198861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial.
    Lyttle MD; Rainford NEA; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee ED; Potter S; Tate P; Iyer A; Evans V; Appleton RE;
    Lancet; 2019 May; 393(10186):2125-2134. PubMed ID: 31005385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for adult convulsive status epilepticus: a multicentre non-inferiority randomised control trial.
    Nakamura K; Marushima A; Takahashi Y; Mochizuki M; Kimura A; Fukuda Y; Asami M; Nakamoto H; Egawa S; Kaneko J; Unemoto K; Kondo Y; Yonekawa C; Uchida M; Hoshiyama E; Yamada T; Maruo K; Ishikawa E; Matsumaru Y; Inoue Y;
    J Neurol Neurosurg Psychiatry; 2023 Jan; 94(1):42-48. PubMed ID: 36207063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.
    Kapur J; Elm J; Chamberlain JM; Barsan W; Cloyd J; Lowenstein D; Shinnar S; Conwit R; Meinzer C; Cock H; Fountain N; Connor JT; Silbergleit R;
    N Engl J Med; 2019 Nov; 381(22):2103-2113. PubMed ID: 31774955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular versus intravenous therapy for prehospital status epilepticus.
    Silbergleit R; Durkalski V; Lowenstein D; Conwit R; Pancioli A; Palesch Y; Barsan W;
    N Engl J Med; 2012 Feb; 366(7):591-600. PubMed ID: 22335736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial.
    Chamberlain JM; Kapur J; Shinnar S; Elm J; Holsti M; Babcock L; Rogers A; Barsan W; Cloyd J; Lowenstein D; Bleck TP; Conwit R; Meinzer C; Cock H; Fountain NB; Underwood E; Connor JT; Silbergleit R; ;
    Lancet; 2020 Apr; 395(10231):1217-1224. PubMed ID: 32203691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety profile of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children.
    Besli GE; Yuksel Karatoprak E; Yilmaz S
    Epilepsy Behav; 2020 Oct; 111():107289. PubMed ID: 32702655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory generalised convulsive status epilepticus : a guide to treatment.
    Kälviäinen R; Eriksson K; Parviainen I
    CNS Drugs; 2005; 19(9):759-68. PubMed ID: 16142991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.